<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01577524</url>
  </required_header>
  <id_info>
    <org_study_id>2009-1350</org_study_id>
    <nct_id>NCT01577524</nct_id>
  </id_info>
  <brief_title>The Use of Diluted Povidone Iodine Irrigation in Spine Surgery</brief_title>
  <official_title>The Use of Diluted Povidone Iodine Irrigation in Spine Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Attabib, Najmedden, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Attabib, Najmedden, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether diluted Povidone Iodine solution used to
      irrigate surgical wounds during spine surgery decreases the incidence of surgical site
      infections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative infections in spine surgery have been extensively investigated in the
      literature. These investigations focus on the efficacy of using peri-operative antibiotics,
      Povidone Iodine skin preparations, the effects of shaving around the surgical sit, and the
      use of intra-operative diluted Povidone Iodine wound irrigation in preventing post-operative
      infections.

      Povidone-iodine is a complex of polyvinyl pyrrolidine and tri-iodine ions widely used as an
      antiseptic agent. It has bactericidal activity against a wide spectrum of pathogens,
      including methicillin-resistant Staphylococcus aureus (MRSA). The safety of its use
      intra-operatively has been evaluated in animal studies and also supported through Randomized
      Controlled Trials in spinal surgery and in other surgical subspecialties.

      The purpose of this study is to evaluate the efficacy of the intra-operative use of diluted
      Povidone Iodine solution in reducing post-operative infections when used for irrigating
      surgical incisions during spinal surgery compared with 0.9% Sodium Chloride Irrigation
      Solution (i.e. normal saline solution).

      The primary outcome measure will be seen as a reduction in the number of post-operative
      infections. As a result and although not directly measured, it is suspected that a reduction
      in post-operative infections may result in quicker healing with fewer complications and pain.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    We had very low recruitment rates that would have resulted in several years being added to the
    study to achieve an appropriate sample size.
  </why_stopped>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of post-operative infections diagnosed in both treatment and control groups</measure>
    <time_frame>Twelve months post operation</time_frame>
    <description>The Centers for Disease Control (CDC)definition of surgical site infections (SSI)will be used for this study.This definition addresses both superficial and deep surgical site infections.
Outcome will be determined by the number of superficial, deep, and total (superficial plus deep) wound infections for each group.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Diluted Povidone Iodine Solution</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline Wash</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Povidone-Iodine</intervention_name>
    <description>Subjects in the treatment group will receive 3.5% diluted Povidone Iodine solution in the surgical incision in a quantity sufficient to fill the wound to the level of the skin. The Povidone Iodine solution will be maintained in the incision for 3 minutes, after which it will be flushed from the wound with normal saline solution.</description>
    <arm_group_label>Diluted Povidone Iodine Solution</arm_group_label>
    <other_name>Betadine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Subjects in the Placebo Comparator group will receive normal saline solution in a quantity sufficient to fill the wound to the level of the skin. The saline solution will be maintained in the incision for 3 minutes, after which it will be flushed from the wound with additional saline solution to replicate the saline wash procedure followed in the Treatment group.</description>
    <arm_group_label>Normal Saline Wash</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of 18-75

          -  Undergoing posterior surgical spinal procedure for degenerative spine disease,
             extra-dural tumors, trauma, or spinal deformity

          -  No obvious potential infective focus

          -  Patient willing to enroll

        Exclusion Criteria:

          -  Age &lt;18 or &gt;75

          -  Identified infective focus in the body, including furuncles,or acne at surgical
             incision site

          -  Patient with discitis or spinal osteomyelitis

          -  Dural tear

          -  Potential use of Bone Morphogenic Protein (BMP)

          -  Iodine hypersensitivity

          -  Out of province patients due to difficulty in arranging follow up visits

          -  Minimal invasive spine surgical procedure (MISS) due to difficulty of having diluted
             Betadine solution contact soft tissue with the use if MISS retractors

          -  Pregnancy

          -  Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Najmedden Attabib, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neurosurgery Department, Saint John Regional Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint John Regional Hospital</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Celik SE, Kara A. Does shaving the incision site increase the infection rate after spinal surgery? Spine (Phila Pa 1976). 2007 Jul 1;32(15):1575-7.</citation>
    <PMID>17621202</PMID>
  </reference>
  <reference>
    <citation>Cheng MT, Chang MC, Wang ST, Yu WK, Liu CL, Chen TH. Efficacy of dilute betadine solution irrigation in the prevention of postoperative infection of spinal surgery. Spine (Phila Pa 1976). 2005 Aug 1;30(15):1689-93.</citation>
    <PMID>16094267</PMID>
  </reference>
  <reference>
    <citation>Georgiade G, Riefkohl R, Georgiade N, Georgiade R, Wildman MF. Efficacy of povidone-iodine in pre-operative skin preparation. J Hosp Infect. 1985 Mar;6 Suppl A:67-71.</citation>
    <PMID>2860178</PMID>
  </reference>
  <reference>
    <citation>Goldenheim PD. In vitro efficacy of povidone-iodine solution and cream against methicillin-resistant Staphylococcus aureus. Postgrad Med J. 1993;69 Suppl 3:S62-5.</citation>
    <PMID>8290460</PMID>
  </reference>
  <reference>
    <citation>Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8.</citation>
    <PMID>1334988</PMID>
  </reference>
  <reference>
    <citation>Rubinstein E, Findler G, Amit P, Shaked I. Perioperative prophylactic cephazolin in spinal surgery. A double-blind placebo-controlled trial. J Bone Joint Surg Br. 1994 Jan;76(1):99-102.</citation>
    <PMID>8300691</PMID>
  </reference>
  <reference>
    <citation>Schubert R. Disinfectant properties of new povidone-iodine preparations. J Hosp Infect. 1985 Mar;6 Suppl A:33-6.</citation>
    <PMID>2860173</PMID>
  </reference>
  <reference>
    <citation>Sindelar WF, Brower ST, Merkel AB, Takesue EI. Randomised trial of intraperitoneal irrigation with low molecular weight povidone-iodine solution to reduce intra-abdominal infectious complications. J Hosp Infect. 1985 Mar;6 Suppl A:103-14.</citation>
    <PMID>2860153</PMID>
  </reference>
  <reference>
    <citation>Strohecker J, Piotrowski WP, Lametschwandtner A. The intra-operative application of povidone-iodine in neurosurgery. J Hosp Infect. 1985 Mar;6 Suppl A:123-5.</citation>
    <PMID>2860156</PMID>
  </reference>
  <reference>
    <citation>Wilson AP, Treasure T, Sturridge MF, Gr√ºneberg RN. A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. Lancet. 1986 Feb 8;1(8476):311-3.</citation>
    <PMID>2868173</PMID>
  </reference>
  <reference>
    <citation>Fang A, Hu SS, Endres N, Bradford DS. Risk factors for infection after spinal surgery. Spine (Phila Pa 1976). 2005 Jun 15;30(12):1460-5.</citation>
    <PMID>15959380</PMID>
  </reference>
  <reference>
    <citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.</citation>
    <PMID>3558716</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2012</study_first_submitted>
  <study_first_submitted_qc>April 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2012</study_first_posted>
  <last_update_submitted>July 13, 2016</last_update_submitted>
  <last_update_submitted_qc>July 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Attabib, Najmedden, M.D.</investigator_affiliation>
    <investigator_full_name>Dr. Najmedden Attabib</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Cadexomer iodine</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

